Sareum Hldgs Plc Total Liabilities
Sareum Hldgs Plc total liabilities. Based on the latest financial reports, Sareum Hldgs Plc (SAR) has total liabilities worth GBX2.04 Million GBX (≈ $248.33 USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sareum Hldgs Plc (SAR) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sareum Hldgs Plc (2004–2025)
Total liabilities of Sareum Hldgs Plc from 2004 to 2025. This chart illustrates how Sareum Hldgs Plc's total liabilities have evolved over time, based on quarterly financial data. Explore SAR long-term investment intensity to see how much of total assets are deployed in long-term investments.
Sareum Hldgs Plc Competitors by Total Liabilities
The table below lists competitors of Sareum Hldgs Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SMG EUROPEAN RECOV. EO 1
F:RCVR
|
Germany | €16.44 Million |
|
London Finance and Investment Group PLC
LSE:LFI
|
UK | GBX257.00K |
|
CANDELARIA MINING CORP
F:29LN
|
Germany | €3.98 Million |
|
Provexis plc
LSE:PXS
|
UK | GBX230.95K |
|
Robinson plc
LSE:RBN
|
UK | GBX20.34 Million |
|
Highbank Resources Ltd.
V:HBK
|
Canada | CA$12.99 Million |
|
Portmeirion Group
LSE:PMGR
|
UK | GBX17.52 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Sareum Hldgs Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sareum Hldgs Plc total assets.
Liquidity & Leverage Metrics
Sareum Hldgs Plc Total Liabilities Ratios Explained
Sareum Hldgs Plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sareum Hldgs Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sareum Hldgs Plc (2004–2025)
The table below shows the annual total liabilities of Sareum Hldgs Plc from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX1.95 Million ≈ $237.62 |
+199.08% |
| 2024-06-30 | GBX653.00K ≈ $79.45 |
-24.68% |
| 2023-06-30 | GBX867.00K ≈ $105.49 |
+90.55% |
| 2022-06-30 | GBX455.00K ≈ $55.36 |
+60.12% |
| 2021-06-30 | GBX284.15K ≈ $34.57 |
+43.12% |
| 2020-06-30 | GBX198.54K ≈ $24.16 |
+35.13% |
| 2019-06-30 | GBX146.93K ≈ $17.88 |
-19.91% |
| 2018-06-30 | GBX183.46K ≈ $22.32 |
+17.95% |
| 2017-06-30 | GBX155.53K ≈ $18.92 |
+56.24% |
| 2016-06-30 | GBX99.55K ≈ $12.11 |
+47.61% |
| 2015-06-30 | GBX67.44K ≈ $8.21 |
+2.48% |
| 2014-06-30 | GBX65.81K ≈ $8.01 |
-17.66% |
| 2013-06-30 | GBX79.92K ≈ $9.72 |
-34.96% |
| 2012-06-30 | GBX122.87K ≈ $14.95 |
+26.67% |
| 2011-06-30 | GBX97.00K ≈ $11.80 |
0.00% |
| 2010-06-30 | GBX97.00K ≈ $11.80 |
+86.54% |
| 2009-06-30 | GBX52.00K ≈ $6.33 |
-88.15% |
| 2008-06-30 | GBX439.00K ≈ $53.41 |
-62.70% |
| 2007-06-30 | GBX1.18 Million ≈ $143.21 |
+102.93% |
| 2006-06-30 | GBX580.00K ≈ $70.57 |
+22.88% |
| 2005-06-30 | GBX472.00K ≈ $57.43 |
-41.73% |
| 2004-06-30 | GBX810.00K ≈ $98.55 |
-- |
About Sareum Hldgs Plc
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical st… Read more